Botulinum toxin B: the new option in cosmetic injection.
Botulinum toxin, one of nature's most toxic substances, is the unlikely source of one of cosmetic dermatology's most popular new injectable treatment options. This article describes the physiological and biological workings of the several structurally similar but antigenically distinct serotypes of botulinum toxin, and provides clinical studies comparing and contrasting the key ingredients in Botox, Dysport, and Myobloc (Neurobloc).
Spencer
James M
JM
Department of Dermatology, Mount Sinai School of Medicine, One Gustave Levy Place, Box 1047, New York, NY 10029, USA.
D000818:Animals; D001905:Botulinum Toxins / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D019274:Botulinum Toxins, Type A / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D003357:Cosmetic Techniques; D004421:Dystonia / Q000188:drug therapy*; D006801:Humans; D007273:Injections, Intramuscular; D008252:Macaca fascicularis; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects
C096323:rimabotulinumtoxinB; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A